Kenneth Lundstrom. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
763
776
.
Zaret G. Denieva, Uliana A. Budanova & Yurii L. Sebyakin. (2021) Irregular cationic lipotetrapeptides for pharmaceutical multifunctional transport systems. Mendeleev Communications 31:4, pages 509-511.
Crossref
Yang Liu & Leaf Huang. 2021. Design and Delivery of SiRNA Therapeutics. Design and Delivery of SiRNA Therapeutics
159
169
.
Kenneth Lundstrom. (2020) Viral Vectors Applied for RNAi-Based Antiviral Therapy. Viruses 12:9, pages 924.
Crossref
Michael J. Wagner, Rahul Mitra, Mark J. McArthur, Wallace Baze, Kirstin Barnhart, Sherry Y. Wu, Cristian Rodriguez-Aguayo, Xinna Zhang, Robert L. Coleman, Gabriel Lopez-Berestein & Anil K. Sood. (2017) Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA). Molecular Cancer Therapeutics 16:6, pages 1114-1123.
Crossref
Nishtha Panwar, Chengbin Yang, Feng Yin, Ho Sup Yoon, Tjin Swee Chuan & Ken-Tye Yong. (2015) RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicles. Nanotechnology 26:36, pages 365101.
Crossref
Eun Jung Lee, So Jin Lee, Yoon-Sik Kang, Ju Hee Ryu, Koo Chul Kwon, Eunji Jo, Ji Young Yhee, Ick Chan Kwon, Kwangmeyung Kim & Jeewon Lee. (2015) Engineered Proteinticles for Targeted Delivery of siRNA to Cancer Cells. Advanced Functional Materials 25:8, pages 1279-1286.
Crossref
Mahtab Dastpak, Maryam M. Matin, Moein Farshchian, Yvan Arsenijevic, Madjid Momeni-Moghaddam, Sajjad Sisakhtnezhad, Sohrab Boozarpour, Hamid Reza Bidkhori, Mahdi Mirahmadi & Ahmad Reza Bahrami. (2014) Construction and Quantitative Evaluation of a Dual Specific Promoter System for Monitoring the Expression Status of Stra8 and c-kit Genes. Molecular Biotechnology 56:12, pages 1100-1109.
Crossref
Maneesh Gujrati, Anthony Malamas, Tesia Shin, Erlei Jin, Yunlu Sun & Zheng-Rong Lu. (2014) Multifunctional Cationic Lipid-Based Nanoparticles Facilitate Endosomal Escape and Reduction-Triggered Cytosolic siRNA Release. Molecular Pharmaceutics 11:8, pages 2734-2744.
Crossref
G. Salzano, R. Riehle, G. Navarro, F. Perche, G. De Rosa & V.P. Torchilin. (2014) Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: A promising strategy to overcome drug resistance in cancer. Cancer Letters 343:2, pages 224-231.
Crossref
Lee Adam Wheeler. (2014) Silencing Sexually Transmitted Infections: Topical siRNA-Based Interventions for the Prevention of HIV and HSV. Infectious Diseases in Obstetrics and Gynecology 2014, pages 1-11.
Crossref
Eveline Edith Salcher & Ernst Wagner. 2014. Nucleic Acid Nanotechnology. Nucleic Acid Nanotechnology
245
260
.
FEIFEI GUO, QINGYING XUN & HUAIJUN ZHOU. (2013) Treatment with Tie2-siRNA in combination with carboplatin suppresses the growth of Ishikawa human endometrial carcinoma cell xenografts in vivo. Oncology Letters 5:6, pages 1777-1782.
Crossref
Lina Cui, Jessica L. Cohen, Crystal K. Chu, Peter R. Wich, Paul H. Kierstead & Jean M. J. Fréchet. (2012) Conjugation Chemistry through Acetals toward a Dextran-Based Delivery System for Controlled Release of siRNA. Journal of the American Chemical Society 134:38, pages 15840-15848.
Crossref
Yan TAN & Xing-Mei ZHANG. (2012) Aptamer Mediated Delivery of Small Interfering RNAs*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 39:5, pages 410-415.
Crossref
Kyung-mi ChoiSeung-Hye ChoiHyesung JeonIn-San KimHyung Jun Ahn. (2011) Chimeric Capsid Protein as a Nanocarrier for siRNA Delivery: Stability and Cellular Uptake of Encapsulated siRNA. ACS Nano 5:11, pages 8690-8699.
Crossref
Ian Holt & Y. Chan N. Pham. 2011. Renewable Resources for Functional Polymers and Biomaterials. Renewable Resources for Functional Polymers and Biomaterials
399
429
.
Diana B. Burr, Samuel A. Molina, Debarshi Banerjee, Derek M. Low & Dolores J. Takemoto. (2011) Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo. Experimental Eye Research 92:4, pages 251-259.
Crossref
Gabriel J. Villares, Maya Zigler & Menashe Bar-Eli. (2011) The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target. Oncotarget 2:1-2, pages 8-17.
Crossref
Ralph A. Tripp & Stephen Mark Tompkins. 2011. RNA Interference. RNA Interference
272
305
.
Min Suk Shim & Young Jik Kwon. (2010)
Efficient and targeted delivery of siRNA
in vivo
. The FEBS Journal 277:23, pages 4814-4827.
Crossref
Andrew V. Oleinikov & Matthew D. Gray. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
40
.
Weiwei Gao, Zeyu Xiao, Alex Radovic-Moreno, Jinjun Shi, Robert Langer & Omid C. Farokhzad. 2010. RNA Therapeutics. RNA Therapeutics
53
67
.
J.C. Gallardo-Pérez, M. Espinosa, G. Ceballos-Cancino, A. Daniel, S. RodrÃguez-EnrÃquez, A. Aviles, R. Moreno-Sánchez, J. Melendez-Zajgla & V. Maldonado. (2009) NF-kappa B is required for the development of tumor spheroids. Journal of Cellular Biochemistry 108:1, pages 169-180.
Crossref
Hui YANG, Dong HUANG, Shai-hong ZHU, Xue-bin YAN, Yong-hong GU, Hui YAN & Li-xiang WU. (2008) Preparation and application of hydroxyapatite(HA) nanoparticles/NR2B-siRNA complex. Transactions of Nonferrous Metals Society of China 18:4, pages 913-918.
Crossref
Zsuzsanna Rácz & Péter Hamar. (2008) SiRNA technology, the gene therapy of the future?. Orvosi Hetilap 149:4, pages 153-159.
Crossref
Alakananda Basu, Shalini D. Persaud & Usha Sivaprasad. 2008. Programmed Cell Death, The Biology and Therapeutic Implications of Cell Death, Part B. Programmed Cell Death, The Biology and Therapeutic Implications of Cell Death, Part B
141
157
.
Michael Famulok, Jörg S. Hartig & Günter Mayer. (2007) Functional Aptamers and Aptazymes in Biotechnology, Diagnostics, and Therapy. Chemical Reviews 107:9, pages 3715-3743.
Crossref
S Sabbioni, E Callegari, M Manservigi, R Argnani, A Corallini, M Negrini & R Manservigi. (2006) Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA. Gene Therapy 14:5, pages 459-464.
Crossref
N Nakai, T Kishida, M Shin-Ya, J Imanishi, Y Ueda, S Kishimoto & O Mazda. (2006) Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf. Gene Therapy 14:4, pages 357-365.
Crossref
Jyotsnabaran Halder, Aparna A. Kamat, Charles N. LandenJr.Jr., Liz Y. Han, Susan K. Lutgendorf, Yvonne G. Lin, William M. Merritt, Nicholas B. Jennings, Arturo Chavez-Reyes, Robert L. Coleman, David M. Gershenson, Rosemarie Schmandt, Steven W. Cole, Gabriel Lopez-Berestein & Anil K. Sood. (2006)
Focal Adhesion Kinase Targeting Using
In vivo
Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy
. Clinical Cancer Research 12:16, pages 4916-4924.
Crossref
James O McNamara, Eran R Andrechek, Yong Wang, Kristi D Viles, Rachel E Rempel, Eli Gilboa, Bruce A Sullenger & Paloma H Giangrande. (2006) Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras. Nature Biotechnology 24:8, pages 1005-1015.
Crossref
Juan Huang, Ping Jiang, Yufeng Li, Jiarong Xu, Wenming Jiang & Xianwei Wang. (2006) Inhibition of porcine reproductive and respiratory syndrome virus replication by short hairpin RNA in MARC-145 cells. Veterinary Microbiology 115:4, pages 302-310.
Crossref
Gregory Cesarone, Cecilia Garofalo, Marc T. Abrams, Olga Igoucheva, Vitali Alexeev, Kyonggeun Yoon, Eva Surmacz & Eric Wickstrom. (2006) RNAi‐mediated silencing of insulin receptor substrate 1 (IRS‐1) enhances tamoxifen‐induced cell death in MCF‐7 breast cancer cells. Journal of Cellular Biochemistry 98:2, pages 440-450.
Crossref
Yi‐Yan Yang, Yong Wang, Ross Powell & Peggy Chan. (2006) POLYMERIC CORE‐SHELL NANOPARTICLES FOR THERAPEUTICS. Clinical and Experimental Pharmacology and Physiology 33:5-6, pages 557-562.
Crossref
S Guo, F Huang & P Guo. (2006) Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells. Gene Therapy 13:10, pages 814-820.
Crossref
Shirin Munir, Kuljeet Kaur & Vivek Kapur. (2006) Avian metapneumovirus phosphoprotein targeted RNA interference silences the expression of viral proteins and inhibits virus replication. Antiviral Research 69:1, pages 46-51.
Crossref
Charles N. LandenJr.Jr., Arturo Chavez-Reyes, Corazon Bucana, Rosemarie Schmandt, Michael T. Deavers, Gabriel Lopez-Berestein & Anil K. Sood. (2005)
Therapeutic
EphA2
Gene Targeting
In vivo
Using Neutral Liposomal Small Interfering RNA Delivery
. Cancer Research 65:15, pages 6910-6918.
Crossref
Teresa de los Santos, Qiaohua Wu, Sonia de Avila Botton & Marvin J. Grubman. (2005) Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. Virology 335:2, pages 222-231.
Crossref
Qing Shao, Hongling Wang, Elizabeth McLachlan, Gregory I.L. Veitch & Dale W. Laird. (2005) Down-regulation of Cx43 by Retroviral Delivery of Small Interfering RNA Promotes an Aggressive Breast Cancer Cell Phenotype. Cancer Research 65:7, pages 2705-2711.
Crossref
Amine Bahi, Frederic Boyer, Manoj Kolira & Jean-Luc Dreyer. (2005) In vivo gene silencing of CD81 by lentiviral expression of small interference RNAs suppresses cocaine-induced behaviour. Journal of Neurochemistry 92:5, pages 1243-1255.
Crossref
P. Young. 2005. Hereditary Peripheral Neuropathies. Hereditary Peripheral Neuropathies
199
205
.
Ciriaco A. Piccirillo, Argyrios N. Theofilopoulos & Gérald J. Prud’homme. 2005. Gene Therapy of Autoimmune Diseases. Gene Therapy of Autoimmune Diseases
43
70
.
Rajnish S. Dave & Roger J. Pomerantz. (2004) Antiviral Effects of Human Immunodeficiency Virus Type 1-Specific Small Interfering RNAs against Targets Conserved in Select Neurotropic Viral Strains. Journal of Virology 78:24, pages 13687-13696.
Crossref
Jack R. Bennink & Tara N. Palmore. (2004) The promise of siRNAs for the treatment of influenza. Trends in Molecular Medicine 10:12, pages 571-574.
Crossref
Wen-Wen Lu, Yueh-Ying Hsu, Jyh-Yuan Yang & Szu-Hao Kung. (2004) Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochemical and Biophysical Research Communications 325:2, pages 494-499.
Crossref